|
PACRGL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.41270000142413E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02480000000005E-05 |
| Normal-vs-Stage2 |
5.198500E-04 |
| Normal-vs-Stage3 |
8.98248142533475E-12 |
| Normal-vs-Stage4 |
4.69209999964804E-07 |
| Stage1-vs-Stage2 |
6.299600E-01 |
| Stage1-vs-Stage3 |
1.029140E-04 |
| Stage1-vs-Stage4 |
4.246000E-02 |
| Stage2-vs-Stage3 |
2.984000E-02 |
| Stage2-vs-Stage4 |
3.147400E-01 |
| Stage3-vs-Stage4 |
2.565200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.14720002783753E-09 |
| Normal-vs-AfricanAmerican |
2.599800E-03 |
| Normal-vs-Asian |
8.856600E-01 |
| Caucasian-vs-AfricanAmerican |
6.386000E-02 |
| Caucasian-vs-Asian |
5.484200E-02 |
| AfricanAmerican-vs-Asian |
1.948990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17580000075424E-08 |
| Normal-vs-Female |
3.5168000001029E-07 |
| Male-vs-Female |
4.000600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.57869999999738E-05 |
| Normal-vs-Age(41-60Yrs) |
7.27760000041044E-08 |
| Normal-vs-Age(61-80Yrs) |
2.85409999967179E-07 |
| Normal-vs-Age(81-100Yrs) |
2.182000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.304000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.334800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.714000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.162000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.223000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.919800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.901000E-01 |
| Normal-vs-Grade 2 |
4.03709999999835E-05 |
| Normal-vs-Grade 3 |
6.78670009079951E-10 |
| Normal-vs-Grade 4 |
1.79790005105929E-09 |
| Grade 1-vs-Grade 2 |
1.326820E-01 |
| Grade 1-vs-Grade 3 |
1.095670E-02 |
| Grade 1-vs-Grade 4 |
3.757400E-03 |
| Grade 2-vs-Grade 3 |
1.089940E-02 |
| Grade 2-vs-Grade 4 |
1.157040E-03 |
| Grade 3-vs-Grade 4 |
1.183760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.95240000000175E-05 |
| Normal-vs-ccB subtype |
1.06430000368363E-08 |
| ccA subtype-vs-ccB subtype |
2.382400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32750000050963E-07 |
| Normal-vs-N1 |
2.340500E-03 |
| N0-vs-N1 |
5.674200E-01 |
|
|
